TrialThe Lancet. Respiratory medicine2022

Effect of a 2-week interruption in methotrexate treatment versus continued treatment on COVID-19 booster vaccine immunity in adults with inflammatory conditions (VROOM study): a randomised, open label, superiority trial.

Abhishek Abhishek et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.